Retinopathy of prematurity: from oxygen management to molecular manipulation.

Published in: Molecular and cellular pediatrics (2023)

There remains an ongoing concern regarding the potential unwanted systemic effects of intravitreally administered anti-VEGF on the overall development of the premature baby. Ongoing dosing studies may lessen these fears by identifying the minimally effective dose required to block extraretinal neovascularisation.

Keyphrases

vascular endothelial growth factor
endothelial cells
case control
human health
single molecule
risk assessment